X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
83
PharmaCompass offers a list of Clazosentan Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clazosentan Sodium manufacturer or Clazosentan Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clazosentan Sodium manufacturer or Clazosentan Sodium supplier.
PharmaCompass also assists you with knowing the Clazosentan Sodium API Price utilized in the formulation of products. Clazosentan Sodium API Price is not always fixed or binding as the Clazosentan Sodium Price is obtained through a variety of data sources. The Clazosentan Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clazosentan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clazosentan, including repackagers and relabelers. The FDA regulates Clazosentan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clazosentan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clazosentan supplier is an individual or a company that provides Clazosentan active pharmaceutical ingredient (API) or Clazosentan finished formulations upon request. The Clazosentan suppliers may include Clazosentan API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clazosentan Drug Master File in Korea (Clazosentan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clazosentan. The MFDS reviews the Clazosentan KDMF as part of the drug registration process and uses the information provided in the Clazosentan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clazosentan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clazosentan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clazosentan suppliers with KDMF on PharmaCompass.
Clazosentan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clazosentan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clazosentan GMP manufacturer or Clazosentan GMP API supplier for your needs.
A Clazosentan CoA (Certificate of Analysis) is a formal document that attests to Clazosentan's compliance with Clazosentan specifications and serves as a tool for batch-level quality control.
Clazosentan CoA mostly includes findings from lab analyses of a specific batch. For each Clazosentan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clazosentan may be tested according to a variety of international standards, such as European Pharmacopoeia (Clazosentan EP), Clazosentan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clazosentan USP).
Market Place
